Aleksey Zholobenko

Title: Aleksey Zholobenko: Innovator in Amphipathic Peptide Technology

Introduction

Aleksey Zholobenko is a notable inventor based in Larchwood, Staffordshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of amphipathic peptides. With a total of 3 patents to his name, Zholobenko's work focuses on innovative methods for delivering therapeutic agents to cells.

Latest Patents

One of Zholobenko's latest patents involves an amphipathic peptide designed for the effective delivery of small molecule agents to cells. This invention outlines a peptide that consists of fewer than 50 amino acid residues, including at least 6 arginine residues, 12 alanine residues, and 6 leucine residues. The peptide may also contain at least one cysteine residue and a specific ratio of arginine to negatively charged amino acids. Additionally, it features a defined ratio of hydrophilic to hydrophobic amino acid residues. This technology is further enhanced by a nanoparticle and cell delivery system that utilizes the amphipathic peptide, making it a promising candidate for therapeutic applications, including the delivery of nucleic acids and other small molecules.

Career Highlights

Throughout his career, Aleksey Zholobenko has worked with esteemed institutions such as The Queen's University of Belfast and Phion Therapeutics Ltd. His experience in these organizations has allowed him to refine his expertise in peptide technology and therapeutic delivery systems.

Collaborations

Zholobenko has collaborated with notable colleagues, including Helen McCarthy and Ashley Davison. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Aleksey Zholobenko's work in amphipathic peptide technology represents a significant advancement in therapeutic delivery systems. His innovative patents and collaborations highlight his commitment to improving medical treatments through scientific research.